369 related articles for article (PubMed ID: 32725355)
1. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma.
Zheng Y; Zhu M; Li M
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2439-2446. PubMed ID: 32725355
[TBL] [Abstract][Full Text] [Related]
2. Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis.
Saito S; Ojima H; Ichikawa H; Hirohashi S; Kondo T
Cancer Sci; 2008 Dec; 99(12):2402-9. PubMed ID: 19038010
[TBL] [Abstract][Full Text] [Related]
3. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522
[TBL] [Abstract][Full Text] [Related]
4. Alpha fetoprotein antagonises benzyl isothiocyanate inhibition of the malignant behaviors of hepatocellular carcinoma cells.
Zhu M; Li W; Guo J; Lu Y; Dong X; Lin B; Chen Y; Zhang X; Li M
Oncotarget; 2016 Nov; 7(46):75749-75762. PubMed ID: 27716619
[TBL] [Abstract][Full Text] [Related]
5. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway.
Zhu M; Li W; Lu Y; Dong X; Lin B; Chen Y; Zhang X; Guo J; Li M
Int J Cancer; 2017 Mar; 140(6):1346-1355. PubMed ID: 27925189
[TBL] [Abstract][Full Text] [Related]
6. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
[TBL] [Abstract][Full Text] [Related]
7. AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway.
Chen T; Dai X; Dai J; Ding C; Zhang Z; Lin Z; Hu J; Lu M; Wang Z; Qi Y; Zhang L; Pan R; Zhao Z; Lu L; Liao W; Lu X
Cell Death Dis; 2020 Oct; 11(10):822. PubMed ID: 33009373
[TBL] [Abstract][Full Text] [Related]
8. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
9. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M
Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430
[TBL] [Abstract][Full Text] [Related]
10. Alpha-fetoprotein accelerates the progression of hepatocellular carcinoma by promoting Bcl-2 gene expression through an RA-RAR signalling pathway.
Zhang C; Zhang J; Wang J; Yan Y; Zhang C
J Cell Mol Med; 2020 Dec; 24(23):13804-13812. PubMed ID: 33090723
[TBL] [Abstract][Full Text] [Related]
11. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.
Wong IH; Lau WY; Leung T; Yeo W; Johnson PJ
Clin Cancer Res; 1999 Dec; 5(12):4021-7. PubMed ID: 10632334
[TBL] [Abstract][Full Text] [Related]
12. Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma.
Iida H; Honda M; Kawai HF; Yamashita T; Shirota Y; Wang BC; Miao H; Kaneko S
Gut; 2005 Jun; 54(6):843-51. PubMed ID: 15888795
[TBL] [Abstract][Full Text] [Related]
13. TCP10L negatively regulates alpha-fetoprotein expression in hepatocellular carcinoma.
Shen S; Feng H; Liu L; Su W; Yu L; Wu J
BMB Rep; 2020 Aug; 53(8):431-436. PubMed ID: 32438969
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.
Sato S; Genda T; Hirano K; Tsuzura H; Narita Y; Kanemitsu Y; Kikuchi T; Iijima K; Wada R; Ichida T
Liver Int; 2012 Oct; 32(9):1382-90. PubMed ID: 22681639
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma.
Fatima S; Luk JM; Poon RT; Lee NP
Expert Rev Mol Diagn; 2014 Jun; 14(5):535-48. PubMed ID: 24809435
[TBL] [Abstract][Full Text] [Related]
16. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
17. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications.
Debruyne EN; Delanghe JR
Clin Chim Acta; 2008 Sep; 395(1-2):19-26. PubMed ID: 18538135
[TBL] [Abstract][Full Text] [Related]
19. CD34, PCNA and CK19 expressions in AFP- hepatocellular carcinoma.
Cui DJ; Wu Y; Wen DH
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5200-5205. PubMed ID: 30178842
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma.
Görög D; Regöly-Mérei J; Paku S; Kopper L; Nagy P
World J Gastroenterol; 2005 Aug; 11(32):5015-8. PubMed ID: 16124056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
